Vimarsana
Biggest News Aggregation in the World

Affymax Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Affymax Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Affymax Inc Today - Breaking & Trending Today

OmniAb, Inc. Appoints Steve Love to its Board of Directors and as Audit Committee Chair - Vimarsana News

OmniAb, Inc. Appoints Steve Love to its Board of Directors and as Audit Committee Chair

OmniAb, Inc. announced the appointment of Steve Love to its Board of Directors. Mr. Love has more than 30 years of financial experience including more than 13 years serving in Chief Financial Officer...

Head to Head Analysis: Affymax (OTCMKTS:AFFY) and Merus (NASDAQ:MRUS) - Vimarsana News

Head to Head Analysis: Affymax (OTCMKTS:AFFY) and Merus (NASDAQ:MRUS)

Merus (NASDAQ:MRUS – Get Rating) and Affymax (OTCMKTS:AFFY – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, earnings and institutional ownership. Valuation & Earnings This table compares Merus and Affymax’s revenue, earnings per […]

Investegate |Prothena Corporation plc Announcements | Prothena Corporation plc: Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors - Vimarsana News

Investegate |Prothena Corporation plc Announcements | Prothena Corporation plc: Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors

Investegate announcements from Prothena Corporation plc, Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors

Prothena Announces Appointment of Biotechnology Industry - Vimarsana News

Prothena Announces Appointment of Biotechnology Industry

DUBLIN, Ireland, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust...

Critical Analysis: Affymax (OTCMKTS:AFFY) & Benitec Biopharma (NASDAQ:BNTC) - Vimarsana News

Critical Analysis: Affymax (OTCMKTS:AFFY) & Benitec Biopharma (NASDAQ:BNTC)

Benitec Biopharma (NASDAQ:BNTC – Get Rating) and Affymax (OTCMKTS:AFFY – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, dividends, analyst recommendations and risk. Institutional and Insider Ownership 20.2% of Benitec Biopharma shares are owned […]